Delivery Order SPE2DB22D3301-SPE2DB23FZ0QV
Award Date 7/5/23
Potential Completion Date 7/26/23
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,279.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 daily 14 mg doses of the pharmaceutical Lenvima. The contract has a period of performance from September 1, 2023 through September 25, 2023, with all work to be conducted by the prime contractor at its facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose (60-count supply) with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded on August 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used in the treatment of various malignancies, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a quantity of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a $9,279.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of the 14 mg daily dose of Lenvima. To be performed in Conshohocken, Pennsylvania from August 21, 2023 through September 12, 2023, this order is likely placed against DLA's Pharmaceutical Prime Vendor contract to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will deliver the specified...
- The Defense Logistics Agency awarded a $9,279.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of the 8 mg daily dose of Lenvima. The delivery order was issued against an existing prime vendor contract vehicle and calls for the delivery of the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by September 8, 2023. Amerisourcebergen will serve as the prime contractor on this order to provide prescription drugs in...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,559.58 to Amerisourcebergen Drug Corporation for the supply of 60 daily 8 mg doses of the pharmaceutical Lenvima. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 31, 2023 through September 22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies,...
- The Defense Logistics Agency Troop Support Medical awarded a $74,238 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561591758 LENVIMA 8 MG daily doses packaged in 60 count bottles. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 25, 2023 through August 15, 2023 to supply the pharmaceutical product Lenvima to support the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency awarded a $9,279.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of 8 mg daily doses of Lenvima. The delivery order was issued against an existing Prime Vendor contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by October 13, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed by the Defense Logistics Agency, the...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ0QVDelivery Order
The Defense Logistics Agency awarded a $9,279.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 daily doses of 14 mg Lenvima oral capsules. To be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, the order is to be completed by July 26, 2023 and was issued under an existing DLA pharmaceutical supply contract vehicle. No set aside designation or subcontractors were indicated. Lenvima is approved to treat types of thyroid cancer and kidney cancer, consistent with DLA's role in supporting the medical readiness of the Department of Defense.
Generated 12/14/23, 10:32 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 7/5/23 |